Statement on the safety of d‐ribose
Bioenergy Life Science, Inc. Type: Statement ...
Ergebnisse durchsuchen
Ergebnisse 1 - 10 von 17
Statement on the safety of taxifolin-rich extract from Dahurian Larch (Larix gmelinii)
European Commission following the provision of additional information by Ametix JSC Type: Statement ...
Statement on the safety of synthetic l-ergothioneine as a novel food – supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women
nda@efsa.europa.eu On request from: European Commission Type: Statement ...
Statement on the safety of EstroG-100™ as a novel food pursuant to Regulation (EC) No 258/97
Commission following the provision of additional information by Naturalendo Tech Co., Ltd Type: Statement ...
Urgent advice on lumpy skin disease
29 July 2016 Contact: alpha@efsa.europa.eu On request from: European Commission Type: Statement ...
Safety of ‘Cetyl Myristoleate Complex’
nda@efsa.europa.eu On request from: European Commission Type: Statement ...
Safety of Cetyl Myristoleate Complex
Statement ...
Use of animal-based measures to assess animal welfare
The overall aim of the work outlined in this statement is to help establish a common framework for ... animals. The statement is mainly intended to support the work of EFSA, and a list of considerations for ... opinion on dairy cattle and another on pigs related to the topic. This statement clarifies some common ...
Safety of “conjugated linoleic acid (CLA) rich oils”
Statement ...
Safety of glucosamine for patients receiving coumarin anticoagulants
Allergies to provide a scientific statement on the safety of glucosamine for patients receiving coumarin ... 25 November 2011 Contact: nda@efsa.europa.eu On request from: EFSA Type: Statement ...